The European Commission has granted orphan drug designation (ODD) for Poxel's PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD).
The decision follows a positive...
The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure's AVT02, a biosimilar for Humira (adalimumab), which is...